| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |